Canada Computed Tomography (CT) Market Size

Canada Computed Tomography Market Analysis

The Canada Computed Tomography Market size is estimated at USD 330.24 million in 2024, and is expected to reach USD 454.79 million by 2029, growing at a CAGR of 6.61% during the forecast period (2024-2029).

The COVID-19 epidemic impacted the market expansion. In July 2021, it was predicted that the delay in surgical treatments for patients with breast cancer caused by COVID-19 will result in 700 additional fatalities in Canada, according to an article in Imaging Technology news. Breast cancer screenings and treatments are gradually recovering to pre-pandemic levels as immunizations are given across the nation. Only 12 new CT scan machines were brought to the nation in 2020, which is the lowest number in the previous 20 years, according to a report provided by the Canadian Association of Radiologists in July 2021. Additionally, CT scans took Canadians 50 to 82 days on average to receive. This exceeds the advised 30-day wait time by 20 to 52 days. Waitlists are significantly longer as a result of COVID-19, placing Canada in a medical imaging crisis. However, COVID-19 has given major market participants the chance to establish their positions with the benefits of computed tomography devices. For instance, Spectrum Dynamics Medical Inc.'s premium digital SPECT/64-slice CT scanner, Veriton-CT64, which is intended for both hybrid imaging for both full body and organ focused, with reduced scan times, acquired a Canadian Medical Device License from Health Canada. With the help of this technology, routine hybrid 3D imaging for scans of the heart, brain, and lungs may be completed in less than 20 minutes. Thus, the market is expected to grow in the future.

The high prevalence rate of chronic diseases, such as cancer, diabetes, cardiovascular diseases, and neurological disorders, is a primary factor driving the Canadian computed tomography market. The country's market is additionally influenced by the nation's ageing population growth, technological developments in the relevant industry, expanding R&D practises, rising investments, and a rise in product releases. The most prevalent chronic illnesses in Canada, according to a report released in August 2020 by Benefits by Design, are arthritis, cancer, diabetes, heart conditions, mental illness, and stroke. In 2020, cancer will account for 30% of all fatalities in Canada, making it the country's leading killer. Heart failure affects 600,000 Canadians, and 50,000 new cases are discovered every year. Due to the high incidence and mortality rate of chronic diseases in the nation, CT scanners will increasingly be used to diagnose these conditions, which will further propel the market. Patients with diabetes are also at a significant risk of developing cancer. Canada is one of the 29 nations in the International Diabetes Federation (IDF) North America and Caribbean region with a prevalence rate of people with diabetes of 10.1%, totaling 2,793,500 cases nationwide, according to the International Diabetes Federation. The nation's high prevalence of diabetes is predicted to drive the market. Additionally, the introduction of new advertisements will raise public knowledge of the usage of CT scanners, which will expand the market in the nation. For instance, the Saugeen Memorial Hospital Foundation Canada began their USD 3 million CT scanner fundraising drive in October 2021 to help pay for the purchase of the CT scanner, its software, and minor upgrades to make room for it. Grey Bruce Health Services will be able to better manage the nation's growing number of CT patients thanks to the arrival of a CT scanner in Saugeen Shores, considerably propelling the market.

The high cost of equipment and CT scan procedures, the absence of adequate reimbursement, the strict regulatory clearance processes, and these factors are anticipated to restrain market expansion in Canada.